Floatz logo

FILGRASTIM

Autologous Stem Cell Transplantation

UNC Lineberger Comprehensive Cancer Centerprotein_peptidePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Autologous Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
Olanzapine
Augusta University
Phase 3B
Plerixafor
Sheba Medical Center
Phase 2B
Bortezomib
UNC Lineberger Comprehensive Cancer Center
Phase 2CCC
Fludarabine
The First Affiliated Hospital of Soochow University
Phase 2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
UNC Lineberger Comprehensive Cancer Center
Phase 2CCC

View all 20 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →